Terms: = Ovarian cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Prognosis
15 results:
1. Prognostic factors and novel nomograms for overall survival and cancer specific survival of malignant ovarian cancer patients with bone metastasis: A SEER-based study.
Luo L; Xu N; Liu Y; Zhong S; Yang S; Chen X
Int J Gynaecol Obstet; 2024 Apr; 165(1):176-187. PubMed ID: 38013509
[TBL] [Abstract] [Full Text] [Related]
2. Impact of estrogen receptor expression on prognosis of ovarian cancer according to antibody clone used for immunohistochemistry: a meta-analysis.
Ng CW; Wong KK
J Ovarian Res; 2022 May; 15(1):63. PubMed ID: 35610648
[TBL] [Abstract] [Full Text] [Related]
3. Circular RNA S-7 promotes ovarian cancer EMT via sponging miR-641 to up-regulate ZEB1 and MDM2.
Zhang F; Xu Y; Ye W; Jiang J; Wu C
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667627
[TBL] [Abstract] [Full Text] [Related]
4. Risk of Gynecologic cancer as Second versus First Primary cancer in Japan.
Ogawa C; Nakamura K; Matsuoka H; Matsubara Y; Haraga J; Masuyama H
Acta Med Okayama; 2020 Apr; 74(2):109-114. PubMed ID: 32341584
[TBL] [Abstract] [Full Text] [Related]
5. Does B7-H4 expression correlate with clinicopathologic characteristics and survival in ovarian cancer?: A systematic review and PRISMA-compliant meta-analysis.
Ye Y; Wang JJ; Li SL; Wang SY; Jing FH
Medicine (Baltimore); 2018 Aug; 97(32):e11821. PubMed ID: 30095655
[TBL] [Abstract] [Full Text] [Related]
6. Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer.
Cai X; Ding H; Liu Y; Pan G; Li Q; Yang Z; Liu W
Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):119-127. PubMed ID: 28069585
[TBL] [Abstract] [Full Text] [Related]
7. The Impact of Underweight Status on the prognosis of ovarian cancer Patients: A Meta-Analysis.
Pergialiotis V; Doumouchtsis SK; Perrea D; Vlachos GD
Nutr Cancer; 2016; 68(6):918-25. PubMed ID: 27351098
[TBL] [Abstract] [Full Text] [Related]
8. Are Early Relapses in Advanced-Stage ovarian cancer Doomed to a Poor prognosis?
Vidal F; Guerby P; Luyckx M; Haddad P; Stoeckle E; Morice P; Leblanc E; Lecuru F; Daraï E; Classe JM; Pomel C; Filleron T; Ferron G; Querleu D; Rafii A
PLoS One; 2016; 11(1):e0147787. PubMed ID: 26820579
[TBL] [Abstract] [Full Text] [Related]
9. Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis.
Li D; Ding CY; Qiu LH
Gynecol Oncol; 2015 Nov; 139(2):355-62. PubMed ID: 26232517
[TBL] [Abstract] [Full Text] [Related]
10. The level of RECQL1 expression is a prognostic factor for epithelial ovarian cancer.
Matsushita Y; Yokoyama Y; Yoshida H; Osawa Y; Mizunuma M; Shigeto T; Futagami M; Imaizumi T; Mizunuma H
J Ovarian Res; 2014 Nov; 7():107. PubMed ID: 25424877
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of PLR in various cancers: a meta-analysis.
Zhou X; Du Y; Huang Z; Xu J; Qiu T; Wang J; Wang T; Zhu W; Liu P
PLoS One; 2014; 9(6):e101119. PubMed ID: 24968121
[TBL] [Abstract] [Full Text] [Related]
12. Expression of tumor-specific antigen MAGE, GAGE and BAGE in ovarian cancer tissues and cell lines.
Zhang S; Zhou X; Yu H; Yu Y
BMC Cancer; 2010 Apr; 10():163. PubMed ID: 20423514
[TBL] [Abstract] [Full Text] [Related]
13. Primary peritoneal carcinoma in a UK cancer center: comparison with advanced ovarian carcinoma over a 5-year period.
Jaaback KS; Ludeman L; Clayton NL; Hirschowitz L
Int J Gynecol Cancer; 2006; 16 Suppl 1():123-8. PubMed ID: 16515579
[TBL] [Abstract] [Full Text] [Related]
14. [Significance of concentration of serum soluble vascular cell adhesion molecule-1 in epithelial ovarian carcinoma].
Qiao XM; Wang ZM
Ai Zheng; 2004 Jan; 23(1):81-4. PubMed ID: 14720381
[TBL] [Abstract] [Full Text] [Related]
15. Positive effusion cytology as the initial presentation of malignancy.
Monte SA; Ehya H; Lang WR
Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
[TBL] [Abstract] [Full Text] [Related]